Q3 2012
Released Nov 14, 2012, during market hours
10-Q filed Nov 14, 2012, 45 days after period end · 0001144204-12-062448
Q3 2012 · 10-Q
Revenue$5.42M$5.42M +6.5% vs Q3 2011+185.9% vs Q2 2012
Net Income$1.07M$1.07M −3.2% vs Q3 2011N/M vs Q2 2012
EPS Diluted$0.07$0.07 ±0.0% vs Q3 2011−46.2% vs Q2 2012
Gross Profit$3,399,000−5.5%
Operating Income$1,073,000−3.0%
Operating Cash Flowderived-$2,694,000N/M
Free Cash Flowderived-$2,795,000N/M
Margins · derived
Gross margin62.8%−8.0 pt vs Q3 2011
Operating margin19.8%−1.9 pt vs Q3 2011
Net margin19.8%−2.0 pt vs Q3 2011
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-Q.
Same quarter
| Metric | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|
| Revenue | $5.42M | $5.08M | $5.20M |
| Net Income | $1.07M | $1.11M | $947.00K |
| EPS Diluted | $0.07 | $0.07 | $0.06 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
ProPhase Labs, Inc. · CIK 868278 · Engraved from SEC EDGAR